Peter MacCallum Cancer Centre, Lead Scientist, Solid Somatic Molecular Pathology Laboratory
BIOGRAPHY
JUL 27, 2022 10:00 AM CEST
Peter MacCallum Cancer Centre validation of the Oncomine™ Precision Assay and experience with the Ion Torrent™ Genexus™ System
Presented at:
Lab Compliance Connect
Speaker
Abstract
Next-generation sequencing (NGS) has become increasingly popular with testing labs, as it allows them to obtain more data in less time and with minimal input.
In this webinar, Dr. Hewitt will share her experience with the Ion Torrent™ Genexus™ System, the first NGS solution that automates the specimen-to-report workflow, along with the Oncomine™ Precision Assay —all while examining the performance characteristics and data.
Learning objectives:
- Provide an overview of Peter MacCallum Cancer Centre
- Discuss solid somatic molecular services provided
- Identify key elements in selecting an NGS assay and sequencer
- Provide an overview of validating the Oncomine Precision Assay
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...